Literature DB >> 25732254

Pheochromocytoma presenting as hyperglycemic hyperosmolar syndrome and unusual fever.

I-Shuan Lee1, Ting-Wei Lee, Chun-Jen Chang, Yu-Mei Chien, Ting-I Lee.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25732254     DOI： 10.1007/s11739-015-1217-5

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  5 in total

1.  Changes in energy metabolism in pheochromocytoma.

Authors:  O Petrák; D Haluzíková; P Kaválková; B Štrauch; J Rosa; R Holaj; A Brabcová Vránková; D Michalsky; M Haluzík; T Zelinka; J Widimsky
Journal:  J Clin Endocrinol Metab       Date:  2013-02-22       Impact factor: 5.958

2.  Biochemical diagnosis of pheochromocytoma: which test is best?

Authors:  Jacques W M Lenders; Karel Pacak; McClellan M Walther; W Marston Linehan; Massimo Mannelli; Peter Friberg; Harry R Keiser; David S Goldstein; Graeme Eisenhofer
Journal:  JAMA       Date:  2002-03-20       Impact factor: 56.272

3.  Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines?

Authors:  Roeland F Stolk; Carel Bakx; Jan Mulder; Henri J L M Timmers; Jacques W M Lenders
Journal:  J Clin Endocrinol Metab       Date:  2013-02-13       Impact factor: 5.958

Review 4.  Subclinical phaeochromocytoma.

Authors:  Massimo Mannelli; Jacques W M Lenders; Karel Pacak; Gabriele Parenti; Graeme Eisenhofer
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.690

5.  Pheochromocytoma mimicking both acute coronary syndrome and sepsis: a case report.

Authors:  Ting-Wei Lee; Ke-Hsun Lin; Chun-Jen Chang; Wei-Han Lew; Ting-I Lee
Journal:  Med Princ Pract       Date:  2012-10-27       Impact factor: 1.927
  5 in total
  1 in total

Review 1.  Glucose Intolerance on Phaeochromocytoma and Paraganglioma-The Current Understanding and Clinical Perspectives.

Authors:  Ichiro Abe; Farhadul Islam; Alfred King-Yin Lam
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-26       Impact factor: 5.555
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.